ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 84 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,964 | +590.6% | 193,474 | +570.1% | 0.01% | +600.0% |
| Q2 2023 | $574 | -70.4% | 28,874 | -74.5% | 0.00% | -66.7% |
| Q1 2023 | $1,942 | -37.5% | 113,374 | -28.6% | 0.00% | -25.0% |
| Q4 2022 | $3,108 | -100.0% | 158,800 | -66.9% | 0.00% | -63.6% |
| Q3 2022 | $7,658,000 | +28.3% | 479,800 | +10.6% | 0.01% | +57.1% |
| Q2 2022 | $5,970,000 | +140.5% | 433,900 | +177.3% | 0.01% | +133.3% |
| Q1 2022 | $2,482,000 | -25.1% | 156,500 | +3.1% | 0.00% | -25.0% |
| Q4 2021 | $3,314,000 | -4.0% | 151,799 | +31.4% | 0.00% | 0.0% |
| Q3 2021 | $3,452,000 | +287.9% | 115,493 | +474.6% | 0.00% | +300.0% |
| Q2 2021 | $890,000 | -63.9% | 20,100 | -63.8% | 0.00% | -66.7% |
| Q1 2021 | $2,467,000 | +88.9% | 55,590 | -40.6% | 0.00% | +200.0% |
| Q1 2020 | $1,306,000 | +301.8% | 93,600 | +235.5% | 0.00% | – |
| Q3 2019 | $325,000 | +7.3% | 27,900 | +61.3% | 0.00% | – |
| Q1 2019 | $303,000 | -42.9% | 17,301 | -51.7% | 0.00% | -100.0% |
| Q4 2018 | $531,000 | -67.7% | 35,818 | -46.4% | 0.00% | -50.0% |
| Q3 2018 | $1,645,000 | -80.2% | 66,825 | -84.5% | 0.00% | -60.0% |
| Q2 2018 | $8,319,000 | +164.6% | 431,320 | +157.2% | 0.01% | +66.7% |
| Q1 2018 | $3,144,000 | – | 167,675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |